Home/Filings/4/0001127602-25-015857
4//SEC Filing

ISHRAK OMAR 4

Accession 0001127602-25-015857

CIK 0000318154other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 9:04 PM ET

Size

5.3 KB

Accession

0001127602-25-015857

Insider Transaction Report

Form 4
Period: 2025-05-23
ISHRAK OMAR
Director
Transactions
  • Award

    Common Stock

    2025-05-23+8096,084.499 total
Footnotes (2)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
  • [F2]These shares include 255 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001523102

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 9:04 PM ET
Size
5.3 KB